Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00211172
Status:
COMPLETED
Last Update Posted:
2014-10-09
First Post:
2005-09-13
Brief Title:
HMO Research Network CERT Acute Myocardial Infarction
Sponsor:
Kaiser Permanente
Organization:
Kaiser Permanente
Study Overview
Official Title:
The HMO Research Network CERT Acute Myocardial Infarction
Status:
COMPLETED
Status Verified Date:
2011-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary goal of this study is to evaluate the effectiveness of direct-to-patient mailings designed to increase patients adherence to prescribed beta-blockers following an acute myocardial infarction AMI
Prior to developing patient materials focus groups were conducted with patient who had previously suffered an acute myocardial infarction AMI to identify the issues and information that patients felt were important to include in our materials as well as the best way to present the information Additionally patient materials were pre-tested with AMI patients to ensure that the materials were clear and easy to read and that the key messages were understood
Prior to developing patient materials focus groups were conducted with patient who had previously suffered an acute myocardial infarction AMI to identify the issues and information that patients felt were important to include in our materials as well as the best way to present the information Additionally patient materials were pre-tested with AMI patients to ensure that the materials were clear and easy to read and that the key messages were understood
Detailed Description:
Specific Aims
1 Assess the persistence of beta blocker use for post-acute myocardial infarction AMI patients following a direct to patient intervention designed to increase rates of evidence-based long-term use of medications beta blockers lipid lowering agents aspirin and ACE inhibitors that increase survival following AMI
2 Describe patient and system characteristics associated with differences in impact of the intervention
Research Design and Methods
We will conduct a randomized controlled trial within the 4 participating HMOs Kaiser Permanente Northwest Harvard Pilgrim Health Care Health Partners and Kaiser Permanente Georgia Inpatient data will be used to identify patients with a primary discharge diagnosis of AMI 4-6 months before the extraction date Practices will be block-randomized to the intervention group or to usual care To increase repetition of the message there will be two personalized mailings occurring at 4-6 months post AMI and at 9 months The first message will include elements in the table below and the repeat message will be shorter but include similar information The message will come from the patients own health plan with the choice of specific individual eg quality assurance department medical director or Chief of Cardiology being informed by our qualitative work This intervention will be done in collaboration with the cardiovascular care committees and quality assurance departments of participating Health Maintenance Organizations HMOs
1 Assess the persistence of beta blocker use for post-acute myocardial infarction AMI patients following a direct to patient intervention designed to increase rates of evidence-based long-term use of medications beta blockers lipid lowering agents aspirin and ACE inhibitors that increase survival following AMI
2 Describe patient and system characteristics associated with differences in impact of the intervention
Research Design and Methods
We will conduct a randomized controlled trial within the 4 participating HMOs Kaiser Permanente Northwest Harvard Pilgrim Health Care Health Partners and Kaiser Permanente Georgia Inpatient data will be used to identify patients with a primary discharge diagnosis of AMI 4-6 months before the extraction date Practices will be block-randomized to the intervention group or to usual care To increase repetition of the message there will be two personalized mailings occurring at 4-6 months post AMI and at 9 months The first message will include elements in the table below and the repeat message will be shorter but include similar information The message will come from the patients own health plan with the choice of specific individual eg quality assurance department medical director or Chief of Cardiology being informed by our qualitative work This intervention will be done in collaboration with the cardiovascular care committees and quality assurance departments of participating Health Maintenance Organizations HMOs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None